Navigation Links
Pfizer Initiates Phase 1 Clinical Trial for FVIIa Hemophilia Drug Candidate Developed by Catalyst Biosciences
Date:1/5/2012

rget proteins underlying diseases.  Catalyst's discovery platform rapidly creates and optimizes tailor-made protease drug candidates that cleave a wide variety of disease targets, either by improving existing protease drugs or by creating new protease drugs, known as Alterase™ therapeutics.  Catalyst is focusing its product development efforts on drug candidates for hemophilia, non-hemophilic bleeding, and complement-driven diseases, including the prevention of delayed graft function and inflammation.  Catalyst has ongoing research, development, and license agreements with Wyeth LLC, a wholly owned subsidiary of Pfizer Inc., and with MedImmune, LLC, the global biologics unit of AstraZeneca plc.  Catalyst is privately held with backing by leading venture firms, including Burrill & Company, Essex Woodlands Health Ventures, HealthCare Ventures, Johnson & Johnson Development Corporation, Morgenthaler Ventures, Novartis BioVentures, RCT BioVentures, and Sofinnova Ventures.  For more information, please visit www.catbio.com.

Catalyst Biosciences, Inc.

William J. Dawson

Chief Financial Officer

+1.650.871.0761

info@catbio.com

BCC Partners for Catalyst Biosciences

Karen L. Bergman

+1.650.575.1509

 

 

 

 


'/>"/>
SOURCE Catalyst Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
2. Kosans Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease
3. Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development
4. Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer
5. NicOx Announces Pfizer Initiates Phase 2 Clinical Development for PF-03187207 in Japan
6. Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug
7. MannKind Addresses Pfizers Announcement Regarding Exubera
8. Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
9. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
10. Medarex Receives Milestone Payment from Pfizer for Investigational New Drug Application Filing
11. Pfizer Contributes Critical Data to URMC Drug Safety Initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... , Oct. 24, 2014  In 2008, two ... large quantities of multiple controlled substances, on a regular ... also reported that Dr. Gurney was practicing "all the ... that one of his employees said that Dr. Gurney ... treatment of patients." Dr. Gurney,s behavior became ...
(Date:10/25/2014)... HOUSTON , Oct. 24, 2014 Burzynski ... Food and Drug Administration (FDA) has given the company ... and AS2-1 in patients > 3 months of age ... will be placed in one of five treatment groups ... have received prior treatment for DIPG. The primary study ...
(Date:10/22/2014)... CLARA, Calif. , Oct. 22, 2014  Cephasonics, ... announced the introduction of the cQUB™-1 (cQuest Ultrasound Box™-1), ... white-label ultrasound systems designed and manufactured by Cephasonics for ... name and model number. Cephasonics will be showcasing the ... being held this week in Chongqing, China ...
Breaking Medicine Technology:Doctors That Harm: The Real Stories Insurance Companies Against Prop 46 Don't Want You To Know, Part 8 of Consumer Watchdog Campaign Series 2Doctors That Harm: The Real Stories Insurance Companies Against Prop 46 Don't Want You To Know, Part 8 of Consumer Watchdog Campaign Series 3Burzynski Research Institute, Inc. Announces FDA Permission to Launch a New Clinical Trial in Diffuse Intrinsic Brainstem Glioma 2Cephasonics Launches the cQUB-1, First Product in New Family of cQUB White-Label Ultrasound Systems Targeted at Medical Applications 2Cephasonics Launches the cQUB-1, First Product in New Family of cQUB White-Label Ultrasound Systems Targeted at Medical Applications 3
... Mardil Inc., a cardiac device company with novel ... advanced its device to first-in-human testing, a milestone ... was successfully implanted with the Mardil device last ... improvement in heart function after the procedure, according ...
... expanded reimbursement coverageMINNEAPOLIS, Jan. 26 Uroplasty, Inc. (Amex: ... patient enrollment in the randomized, controlled multicenter clinical study ... of overactive bladder (OAB) symptoms of urinary urgency, urge ... of 214 patients have enrolled two months ahead of ...
Cached Medicine Technology:Mardil Inc. Advances Its Novel Cardiac Device to First-In-Human Trials for Mitral Valve Regurgitation 2Patient Enrollment in Urgent(R) PC SUmiT Clinical Trial Completed Ahead of Schedule 2Patient Enrollment in Urgent(R) PC SUmiT Clinical Trial Completed Ahead of Schedule 3Patient Enrollment in Urgent(R) PC SUmiT Clinical Trial Completed Ahead of Schedule 4
(Date:10/25/2014)... -- Researchers who discovered antibiotics in farmed and ... concern. The use of antibiotics in animals, ... contribute to the development of antibiotic-resistant bacteria that ... the study. Each year in the United ... and kill about 23,000, according to the Infectious ...
(Date:10/22/2014)... 2014 At a time when the ... and athletes at all levels, the UPMC Sports ... current discussion where two powerful messages are lost: Concussions ... result in full recoveries every day. , In striving ... fact and research, UPMC and the Concussion Program are ...
(Date:10/22/2014)... 22, 2014 For Dr. Iris Hunter, a ... it’s an extension of her life’s mission. Her extensive experience ... the owner of FirstLight HomeCare, make it clear that Hunter’s ... me that my work makes a difference in the lives ... spirit, so after much research, I felt ready to start ...
(Date:10/22/2014)... October 22, 2014 Hay House is pleased ... Addiction and Upgrade Your Life (Paperback; $10.82) written by the ... & Recovery. This book is meant to help readers ... life of recovery. , Recovery 2.0 is not the ... Recovery 2.0 is a guide for what comes next. ...
(Date:10/22/2014)... Losing Weight Your Body’s Way , In ... in the face, it certainly can be difficult to choose ... an extra favor by doing it the healthy way? Set ... listen to your body, exercise regularly, and choose foods with ... losing weight; you need to exercise more and eat less. ...
Breaking Medicine News(10 mins):Health News:Researchers Say Antibiotics in Fish a Health Concern 2Health News:University of Pittsburgh Medical Center Launches Initiative to Emphasize Concussions Are Treatable 2Health News:University of Pittsburgh Medical Center Launches Initiative to Emphasize Concussions Are Treatable 3Health News:University of Pittsburgh Medical Center Launches Initiative to Emphasize Concussions Are Treatable 4Health News:Dr. Iris Hunter to Host Grand Opening of FirstLight HomeCare Tomorrow 2Health News:Hay House Announces The Official Release of Recovery 2.0: Move Beyond Addiction and Upgrade Your Life 2Health News:Hay House Announces The Official Release of Recovery 2.0: Move Beyond Addiction and Upgrade Your Life 3Health News:ReductionGuruMD Presents Ways to Improve Your Weight Loss Results 2
... Group, Inc., the parent company of Ruth,s Chris Steak House, ... Broad Street Ruth,s Chris Steak House to Tulane University for ... Center, a neighborhood-based medical home that will provide care to ... The building will honor the restaurant company,s founder, ...
... Cardinal Health today announced its board of directors ... pro rata distribution of at least 80 percent of ... shareholders, with Cardinal Health retaining the remaining shares. , ... after concluding that, as separate companies, both Cardinal Health ...
... ... deliver results-based incentives for wellness programs. , ... Columbus, OHIO (Vocus) July 10, 2009 -- CBCA Administrators, Inc. ... for wellness programs., , ,Understanding the impact that unhealthy lifestyles will have on future ...
... can help ward off stress and depression, study says , ... the positive things that happen in your daily life can ... with tough times, study findings show. , In a recent ... period, instead of answering general questions such as how much ...
... 10 Surfers, cancer survivors and supporters ... Pacific Ocean with a special purpose: to show their support for ... Survivor Beach, they will place their surfboards in the sand, one-by-one, ... surfboards. The line will start at Scripps Pier and continue ...
... , BILLERICA, Mass., July 10 Millipore ... and services for the global life science industry, including ... has filed a lawsuit in the United States District ... & Associates for infringement of Millipore,s patent rights under ...
Cached Medicine News:Health News:Ruth's Hospitality Group Inc. donates Broad Street building to Tulane 2Health News:Ruth's Hospitality Group Inc. donates Broad Street building to Tulane 3Health News:Cardinal Health Board of Directors Approves CareFusion Spinoff 2Health News:Cardinal Health Board of Directors Approves CareFusion Spinoff 3Health News:Cardinal Health Board of Directors Approves CareFusion Spinoff 4Health News:Cardinal Health Board of Directors Approves CareFusion Spinoff 5Health News:Cardinal Health Board of Directors Approves CareFusion Spinoff 6Health News:CBCA Administrators, Inc. Announces Partnership with Bravo Wellness 2Health News:Savoring Happy Moments Helps Build Emotional Strength 2Health News:Moores UCSD Cancer Center Luau and Longboard Invitational Hosts Survivor Beach Aug. 9 2Health News:Moores UCSD Cancer Center Luau and Longboard Invitational Hosts Survivor Beach Aug. 9 3Health News:Millipore Sues W.L. Gore & Associates for Patent Infringement 2Health News:Millipore Sues W.L. Gore & Associates for Patent Infringement 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: